Literatur
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791
Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR (2019) Imaging and impact of myocardial fibrosis in aortic stenosis. JACC Cardiovasc Imaging 12:283–296
Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75
Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK et al (2020) Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med 382:111–119
Pibarot P, Messika-Zeitoun D, Ben-Yehuda O, Hahn RT, Burwash IG, Van Mieghem NM et al (2019) Moderate aortic stenosis and heart failure with reduced ejection fraction: Can imaging guide us to therapy? JACC Cardiovasc Imaging 12:172–184
von Knobelsdorff-Brenkenhoff F (2017) Advanced assessment of aortic stenosis reflecting the complex interplay of valve, ventricle, vessel, and flow. Circ Cardiovasc Imaging 10:e6594
von Knobelsdorff F (2019) Myokardnarbe als Prognoseindikator bei Aortenklappenstenose. Kardiologe 13:123–124
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. von Knobelsdorff gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
von Knobelsdorff, F. Herz-MRT bei Aortenklappenstenose: Bedeutung des Fibrosemarkers „ECV“ zur Prognoseabschätzung. Kardiologe 14, 337–338 (2020). https://doi.org/10.1007/s12181-020-00403-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-020-00403-2